Area of research
Psychiatry and Mental health · Pathology and Forensic Medicine
Research interest
Research interests include Medicine, Migraine, Placebo, Calcitonin gene-related peptide, Dosing, and Tolerability.
Impact of chronic migraine attacks and their severity on the endogenous μ-opioid neurotransmission in the limbic system
Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine
Fremanezumab for the Preventive Treatment of Chronic Migraine
Fremanezumab as Add‐On Treatment for Patients Treated With Other Migraine Preventive Medicines
Prevention of stress- or nitric oxide donor-induced medication overuse headache by a calcitonin gene-related peptide antibody in rodents
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
Therapeutic antibodies against CGRP or its receptor
Calcitonin Gene‐Related Peptide ( <scp>CGRP</scp> ) and Migraine Current Understanding and State of Development